Zimmer Biomet Holdings, Inc. ZBH

91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Zimmer Biomet Holdings, Inc. (ZBH) EV/Sales

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 2.7× (May 2026) to 7.3× (April 2021); the current reading is higher than 2% of that period. That is above the Medical Devices industry median of 2.4× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 3.0× (14.97%)
FY2024 3.5× (14.86%)
FY2023 4.2× (9.99%)
FY2022 4.6× (2.90%)
FY2021 4.7× (24.01%)
FY2020 6.2× 33.34%
FY2019 4.7× 28.69%
FY2018 3.6× (16.27%)
FY2017 4.3× 8.74%
FY2016 4.0× (16.60%)

Quarterly

Period EV/Sales Change
Jun 2026 2.8× (5.43%)
Mar 2026 2.9× (2.32%)
Dec 2025 3.0× (8.60%)
Sep 2025 3.3× 2.73%
42 more quarters

Against its own ten years

Low 2.7× High 7.3×
Ten-year median 4.3×
Current reading's percentile 2

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.4×
PHG Koninklijke Philips N.V. compare 1.4×
GEHC GE HealthCare Technologies Inc. compare 1.9×
ZBH Zimmer Biomet Holdings, Inc. 2.9×
GMED Globus Medical, Inc. compare 3.3×
BIO.B Bio-Rad Laboratories, Inc. compare 3.6×
STE STERIS plc compare 3.6×
BIO Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. compare 7.9×
Medical Devices industry median 2.4×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ZBH